| Product Code: ETC11390575 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antiemetics Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antiemetics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antiemetics Drugs Market - Industry Life Cycle |
3.4 Israel Antiemetics Drugs Market - Porter's Five Forces |
3.5 Israel Antiemetics Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Antiemetics Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Antiemetics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Antiemetics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of nausea and vomiting due to various medical conditions |
4.2.2 Growing awareness about the availability and benefits of antiemetic drugs |
4.2.3 Rising demand for chemotherapy and radiation therapy, which often cause nausea and vomiting |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of antiemetic drugs |
4.3.2 Presence of alternative therapies such as acupuncture and ginger-based remedies |
4.3.3 Potential side effects associated with long-term use of antiemetic drugs |
5 Israel Antiemetics Drugs Market Trends |
6 Israel Antiemetics Drugs Market, By Types |
6.1 Israel Antiemetics Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Antiemetics Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Israel Antiemetics Drugs Market Revenues & Volume, By Serotonin Receptor Antagonists, 2021 - 2031F |
6.1.4 Israel Antiemetics Drugs Market Revenues & Volume, By Dopamine Antagonists, 2021 - 2031F |
6.1.5 Israel Antiemetics Drugs Market Revenues & Volume, By NK1 Receptor Antagonists, 2021 - 2031F |
6.2 Israel Antiemetics Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Antiemetics Drugs Market Revenues & Volume, By Chemotherapy-Induced Nausea, 2021 - 2031F |
6.2.3 Israel Antiemetics Drugs Market Revenues & Volume, By Motion Sickness, 2021 - 2031F |
6.2.4 Israel Antiemetics Drugs Market Revenues & Volume, By Post-Surgical Nausea, 2021 - 2031F |
6.3 Israel Antiemetics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Antiemetics Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.3 Israel Antiemetics Drugs Market Revenues & Volume, By Online, 2021 - 2031F |
6.3.4 Israel Antiemetics Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 Israel Antiemetics Drugs Market Import-Export Trade Statistics |
7.1 Israel Antiemetics Drugs Market Export to Major Countries |
7.2 Israel Antiemetics Drugs Market Imports from Major Countries |
8 Israel Antiemetics Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed antiemetic drug regimens |
8.2 Number of clinical trials investigating the effectiveness of new antiemetic drugs |
8.3 Rate of adoption of antiemetic drugs in different medical specialties |
9 Israel Antiemetics Drugs Market - Opportunity Assessment |
9.1 Israel Antiemetics Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Antiemetics Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Antiemetics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Antiemetics Drugs Market - Competitive Landscape |
10.1 Israel Antiemetics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Antiemetics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here